(Go: >> BACK << -|- >> HOME <<)

<Omega>-3 PUFA Attenuates LPS-Induced Neuro-Injury of Neonatal Rats through the PI3K/AKT Pathway

Neuroscience. 2019 Aug 21:414:112-127. doi: 10.1016/j.neuroscience.2019.06.027. Epub 2019 Jun 29.

Abstract

Inflammation may result in periventricular leukomalacia, which is the leading cause of preterm brain encephalopathy. Moreover, <omega>-3 polyunsaturated fatty acids (<omega>-3 PUFAs) play a pivotal role against central nervous system injury, which is likely related to its anti-inflammatory effect. However, the mechanism regarding the remedial effects of <omega>-3 PUFA for LPS-induced neuro-injury has remained unclear. In this study, newborn SD rats were intraperitoneally injected with LPS or < omega>-3 PUFA, and the proliferation and apoptosis of neurocytes in the hippocampus were measured by TUNEL and BrdU. Quantitative real-time PCR (qPCR) and Western blot assay were used to analyze the mRNA and protein levels of PI3K, AKT and β-catenin in vitro and in vivo. We found that <omega>-3 PUFA promoted the proliferation and migration of neurocytes in vitro and in vivo and inhibited apoptosis. Furthermore, we confirmed that <omega>-3 PUFA through the PI3K/AKT signaling pathway positively regulated the expression of PI3K and further caused the phosphorylation of AKT activation, followed by the upregulation of β-catenin expression. Interestingly, this phenomenon became more noticeable with the combined application of <omega>-3 PUFA and a PI3K/AKT agonist. In conclusion, we confirm that <omega>-3 PUFA plays an important role in neuroprotection by activating the PI3K/AKT/β-catenin pathway. It may be a promising strategy against brain injury.

Keywords: -3 PUFA; LPS; PI3K/AKT pathway; neuroprotection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Apoptosis / drug effects
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Fatty Acids, Omega-3 / pharmacology*
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Lipopolysaccharides / pharmacology*
  • Male
  • Neurons / drug effects
  • Neurons / metabolism
  • Neuroprotection / drug effects
  • Neuroprotective Agents / pharmacology*
  • PC12 Cells
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects*

Substances

  • Fatty Acids, Omega-3
  • Lipopolysaccharides
  • Neuroprotective Agents
  • Proto-Oncogene Proteins c-akt